Search results
Results from the WOW.Com Content Network
This psychiatric assessment tools allows for the monitoring of side effects related to neuroleptic (or anti-psychotic) medications. The test is a self-reported check-tick box format with a predefined scale from "not at all" to "very much". The test asks 51 questions in all with a number being red herrings to
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.
Cover of Hare's Psychopathy Checklist-Revised (2nd ed., 2003). The Psychopathy Checklist or Hare Psychopathy Checklist-Revised, now the Psychopathy Checklist—revised (PCL-R), is a psychological assessment tool that is commonly used to assess the presence and extent of psychopathy in individuals—most often those institutionalized in the criminal justice system—and to differentiate those ...
The Psychopathic Personality Inventory (PPI-Revised) is a personality test for traits associated with psychopathy in adults. The PPI was developed by Scott Lilienfeld and Brian Andrews to assess these traits in non-criminal (e.g. university students) populations, though it is still used in clinical (e.g. incarcerated) populations as well.
The General Health Questionnaire (GHQ) is a psychometric screening tool to identify common psychiatric conditions. [1] It has been translated and validated in at least two languages in addition to English, including Spanish [2] and Persian. [3] The latter used in different fields and generations. [4]
The General Behavior Inventory (GBI) is a 73-question psychological self-report assessment tool designed by Richard Depue [1] [2] [failed verification] and colleagues to identify the presence and severity of manic and depressive moods in adults, as well as to assess for cyclothymia.
The PHQ-9 is brief, free to use, and easy to score. It has good specificity, but the poor sensitivity could lead to false negatives, [26] which is a problem for a screening tool. It is likely to perform best in samples where the prevalence of depressive disorders is high. [25]
The BSDS is a well validated diagnostic tool with a high sensitivity (0.76) and specificity (0.93) score. [2] It was also found to have a high Negative Predictive Value (NPV) of 0.87, suggesting that 87% of the patients who scored below 13 points on the BSDS were correctly identified as not having BD.